期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Dendritoma therapy of transferrable brain glioma in mice: An experimental study
1
作者 Ning Jiang changwu dou +1 位作者 Fuming Tian Xiangdong Zhao 《Discussion of Clinical Cases》 2015年第4期6-9,共4页
Glioma is the most common central nervous system primary tumor,accounting for about 40%of intracranial tumors.In recent years,studies have shown that the human brain is not immune-free zone.The low immunogenicity of t... Glioma is the most common central nervous system primary tumor,accounting for about 40%of intracranial tumors.In recent years,studies have shown that the human brain is not immune-free zone.The low immunogenicity of the tumor itself,tumor-generated immunosuppressive factors,and the low immunity of tumor patients all contribute to the“immune escape”phenomenon of glioma cells.Dendritic cells(DCs),as the strongest antigen-presenting cells in the body,play an important role in tumor immunotherapy with T-cell recognizing tumor antigens as the core.Therefore,it is necessary to adopt a strategy of culturing and sensitizing DC cells in vitro to increase their number and improve their function before returning to the body for treatment of patients with glioma. 展开更多
关键词 GLIOMA Intracranial tumors
下载PDF
Molecular diagnosis and treatment of meningiomas:an expert consensus(2022) 被引量:1
2
作者 Jiaojao Deng Lingyang Hua +28 位作者 Liuguan Bian Hong Chen Ligang Chen Hongwei Cheng changwu dou Dangmurenjiapu Geng Tao Hong Hongming Ji Yugang Jiang Qing Lan Gang Li Zhixiong Liu Songtao Qi Yan Qu Songsheng Shi Xiaochuan Sun Hajun Wang Yongping You Hualin Yu Shuyuan Yue Jianming Zhang Xiaohua Zhang Shuo Wang Ying Mao Ping Zhong Ye Gong Group of Neuro-Oncology Society of Neurosurgery Chinese Medical Association 《Chinese Medical Journal》 SCIE CAS CSCD 2022年第16期1894-1912,共19页
Meningiomas are the most common primary intracranial neoplasm with diverse pathological types and complicated clinical manifestations.The fifth edition of the WHO Classification of Tumors of the Central Nervous System... Meningiomas are the most common primary intracranial neoplasm with diverse pathological types and complicated clinical manifestations.The fifth edition of the WHO Classification of Tumors of the Central Nervous System(WHO CNS5),published in 2021,introduces major changes that advance the role of molecular diagnostics in meningiomas.To follow the revision of WHO CNS5,this expert consensus statement was formed jointly by the Group of Neuro-Oncology,Society of Neurosurgery,Chinese Medical Association together with neuropathologists and evidence-based experts.The consensus provides reference points to integrate key biomarkers into stratification and clinical decision making for meningioma patients. 展开更多
关键词 Clinical diagnosis Expert consensus MENINGIOMA Molecular subtyping Therapeutic treatment
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部